Emerald Advisers, LLC Insmed Inc Transaction History

Emerald Advisers, LLC

$2.36 Billion
Q1 2024

A detailed history of Emerald Advisers, LLC transactions in Insmed Inc stock. As of the latest transaction made, Emerald Advisers, LLC holds 630,179 shares of INSM stock, worth $40.6 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

630,179

Previous 930,849 32.3%

Holding current value

$40.6 Million

Previous $28.8 Million 40.74%

% of portfolio

0.72%

Previous 1.29%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$25.72 - $29.94 $7.73 Million - $9 Million	-300,670 Reduced 32.3%	630,179 $17.1 Million
Q4 2023 Feb 05, 2024	SELL	$23.42 - $31.74 $156,141 - $211,610	-6,667 Reduced 0.71%	930,849 $28.8 Million
Q3 2023 Oct 26, 2023	SELL	$19.86 - $26.93 $1.02 Million - $1.39 Million	-51,510 Reduced 5.21%	937,516 $23.7 Million
Q2 2023 Jul 25, 2023	SELL	$16.44 - $21.1 $28,868 - $37,051	-1,756 Reduced 0.18%	989,026 $20.9 Million
Q1 2023 May 04, 2023	SELL	$16.26 - $21.73 $67,170 - $89,766	-4,131 Reduced 0.42%	990,782 $16.9 Million

Q4 2022 Feb 03, 2023	BUY	$16.98 - $23.15 $16.9 Million - $23 Million	994,913 New	994,913 $19.9 Million
Q1 2020 Apr 30, 2020	SELL	$13.63 - $33.98 $9.19 Million - $22.9 Million	-674,167 Closed	0 $0
Q4 2019 Jan 29, 2020	SELL	$16.12 - $24.98 $5.01 Million - $7.76 Million	-310,820 Reduced 31.56%	674,167 $16.1 Million
Q3 2019 Oct 31, 2019	BUY	$15.49 - $25.78 $1.08 Million - $1.79 Million	69,468 Added 7.59%	984,987 $17.4 Million
Q2 2019 Jul 31, 2019	SELL	$23.0 - $32.19 $138,184 - $193,397	-6,008 Reduced 0.65%	915,519 $23.4 Million
Q1 2019 May 01, 2019	BUY	$13.91 - $31.15 $4.43 Million - $9.92 Million	318,482 Added 52.81%	921,527 $26.8 Million
Q4 2018 Jan 30, 2019	SELL	$11.6 - $18.7 $2.19 Million - $3.52 Million	-188,429 Reduced 23.81%	603,045 $7.91 Million
Q3 2018 Oct 31, 2018	BUY	$18.95 - $28.08 $1.38 Million - $2.04 Million	72,585 Added 10.1%	791,474 $16 Million
Q2 2018 Jul 31, 2018	SELL	$20.0 - $29.72 $161,140 - $239,454	-8,057 Reduced 1.11%	718,889 $17 Million
Q1 2018 Apr 26, 2018	SELL	$21.69 - $32.99 $2.86 Million - $4.36 Million	-132,065 Reduced 15.37%	726,946 $16.4 Million
Q4 2017 Feb 05, 2018	SELL	$26.43 - $31.78 $107,358 - $129,090	-4,062 Reduced 0.47%	859,011 $26.8 Million
Q3 2017 Oct 30, 2017	BUY	$11.61 - $31.21 $10 Million - $26.9 Million	863,073	863,073 $26.9 Million

Others Institutions Holding INSM

# of Institutions

340

Shares Held

141M

Call Options Held

2.25M

Put Options Held

3.11M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $8.74B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Account

Emerald Advisers, LLC Insmed Inc Transaction History